EQUITY-BASED INCENTIVE PLANS - Nonvested Restricted Stock Activity (Details) $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2025 USD ($) $ / shares shares
RSAs
Shares
Number of nonvested shares outstanding, beginning	67,668
Nonvested shares granted	40,777
Nonvested shares vested	(108,445)
Nonvested shares forfeited	0
Number of nonvested shares outstanding, ending	0
Weighted Average Grant Date Fair Value
Weighted average exercise price outstanding, beginning (in usd per share) | $ / shares	$ 3.63
Weighted average exercise price outstanding, nonvested options granted (in usd per share) | $ / shares	3.68
Weighted average exercise price outstanding, options vested (in usd per share) | $ / shares	3.65
Weighted average exercise price outstanding, options forfeited (in usd per share) | $ / shares	0
Weighted average exercise price outstanding, ending (in usd per share) | $ / shares	$ 0
RSUs
Shares
Nonvested shares vested	(629,486)
Number of nonvested shares outstanding, ending	174,157
Unrecognized stock-based compensation expense | $	$ 1,762
Restricted Shares
Nonvested restricted stock outstanding, beginning balance (in shares)	833,195
Nonvested restricted stock granted (in shares)	193,032
Nonvested restricted stock vested (in shares)	(521,041)
Nonvested restricted stock forfeited (in shares)	0
Nonvested restricted stock outstanding, ending balance (in shares)	505,186
Weighted Average Grant Date Fair Value
Weighted average exercise price outstanding, beginning (in usd per share) | $ / shares	$ 4.42
Weighted average exercise price outstanding, nonvested options granted (in usd per share) | $ / shares	3.73
Weighted average exercise price outstanding, options vested (in usd per share) | $ / shares	4.46
Weighted average exercise price outstanding, options forfeited (in usd per share) | $ / shares	0
Weighted average exercise price outstanding, ending (in usd per share) | $ / shares	$ 4.11
Weighted average remaining vesting period	10 months 24 days
Performance Shares
Shares
Unrecognized stock-based compensation expense | $	$ 831
Restricted Shares
Nonvested restricted stock outstanding, beginning balance (in shares)	1,981,464
Nonvested restricted stock granted (in shares)	0
Nonvested restricted stock vested (in shares)	0
Nonvested restricted stock forfeited (in shares)	0
Nonvested restricted stock outstanding, ending balance (in shares)	1,981,464
Weighted Average Grant Date Fair Value
Weighted average exercise price outstanding, beginning (in usd per share) | $ / shares	$ 4.61
Weighted average exercise price outstanding, nonvested options granted (in usd per share) | $ / shares	0
Weighted average exercise price outstanding, options vested (in usd per share) | $ / shares	0
Weighted average exercise price outstanding, options forfeited (in usd per share) | $ / shares	0
Weighted average exercise price outstanding, ending (in usd per share) | $ / shares	$ 4.61
Weighted average remaining vesting period	1 year